EpCAM- and EGFR-targeted selective gene therapy for biliary cancers using Z33-fiber-modified adenovirus.
Kawashima R, Abei M, Fukuda K, Nakamura K, Murata T, Wakayama M, Seo E, Hasegawa N, Mizuguchi H, Obata Y, Hyodo I, Hamada H, Yokoyama KK.
Kawashima R, et al. Among authors: hamada h.
Int J Cancer. 2011 Sep 1;129(5):1244-53. doi: 10.1002/ijc.25758. Epub 2011 Jan 6.
Int J Cancer. 2011.
PMID: 21710497